Advertisement

Central European Journal of Medicine

, Volume 2, Issue 3, pp 304–312 | Cite as

Cardiac valve calcifications and predictive parameters in hemodialysis patients

  • Yusuf Selcoki
  • Faruk Turgut
  • Mehmet Kanbay
  • Adem Ozkara
  • Oguz Tekin
  • Burak Uz
  • Ali Akcay
Research Article

Abstract

Cardiac valvular calcification is frequent among hemodialysis (HD) patients. The presence of valvular calcification can help identify HD patients with a higher risk for cardiovascular diseases. Our aim was to determine the prevalence of valvular calcification (VC) in our maintenance hemodialysis (HD) population and to examine some possible etiologic factors for its occurrence. We studied forty-four patients on hemodialysis (23 women and 21 men; mean age 57 ± 18 year; mean HD duration 34 ± 28 months). Valvular calcification (VC) was observed in 21 patients (48%). Of these patients, 6 patients (13%) had mitral valvular calcification, 9 patients (20%) had aortic valvular calcification, and 6 patients (13%) had calcification of both valves. The patients with VC were older than patients without VC (66±14 vs. 50±18). The patients with aortic calcification had longer HD duration than others (48±29 vs. 27±24 months). Patients with VC had higher systolic and diastolic blood pressures than patients without VC. The patients with mitral calcification had higher C-reactive protein (CRP) levels (14 ± 13 vs. 7 ± 7). No significant differences were found with respect to calcium, phosphorus, parathyroid hormone, alkaline phosphatase and mean Ca × P product. Our study confirmed that there is an increased prevalence of VC in HD patients. Age is a risk factor for cardiac VC in HD patients. Longer HD duration was associated with aortic valve calcification. In addition, elevated level of CRP is associated with mitral valve calcification in HD patients.

Keywords

Cardiac valve calcification hemodialysis echocardiography 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    G. Coen, M. Manni, D. Mantella and G. Splendiani: “Can cardiovascular calcifications be prevented in chronic kidney disease?”, G. Ital. Nefrol., Vol. 23, (2006), pp. 21–26.Google Scholar
  2. [2]
    P. Jungers, T. Nguyen Khoa, Z.A. Massy, J. Zingraff, M. Labrunie, B. Descamps-Latscha and N.K. Man: “Incidence of atherosclerotic arterial occlusive accidents in predialysis and dialysis patients”, Nephrol. Dial. Transpl., Vol. 14, (1999), pp. 898–902.CrossRefGoogle Scholar
  3. [3]
    J. Braun, M. Oldendorf, W. Moshage, R. Heidler, E. Zeitler and F.C. Luft: “Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients”, Am. J. Kidney Dis., Vol. 27(3), (1996), pp. 394–401.PubMedGoogle Scholar
  4. [4]
    R. Sharma, D. Pellerin, D.C. Gaze, R.L. Mehta, H. Gregson, C.P. Streather, P.O. Collinson and S.J.D. Brecker: “Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease”, Atherosclerosis, (2006).Google Scholar
  5. [5]
    V. Panuccio, R. Tripepi, G. Tripepi, F. Mallamaci, F.A. Benedetto, A. Cataliotti, I. Bellanuova, G. Giacone, L.S. Malatino and C. Zoccali: “Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients”, Am. J. Kidney Dis., Vol. 43(3), (2004), pp. 479–484.PubMedCrossRefGoogle Scholar
  6. [6]
    A.Y. Wang, M. Wang, J. Woo, C.W. Lam, P.K. Li, S.F. Lui and J.E. Sanderson: “Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study”, J. Am. Soc. Nephrol., Vol. 14(1), (2003), pp. 159–168.PubMedCrossRefGoogle Scholar
  7. [7]
    G.A. Block, T.E. Hulbert-Shearon, N.W. Levin and F.K. Port: “Association of serum phosphorus and calcium × phosphate product with increased mortality in chronic hemodialysis patients: a national study”, Am. J. Kidney Dis., Vol. 31(4), (1998), pp.607–617.PubMedGoogle Scholar
  8. [8]
    M. Ketteler, P. Bongartz, R. Westenfeld, J.E. Wildberger, A.H. Mahnken, R. Bohm, T. Metzger, C. Wanner, W. Jahnen-Dechent and J. Floege: “Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study”, Lancet, Vol. 361(9360),(2003), pp. 827–833.PubMedCrossRefGoogle Scholar
  9. [9]
    S. Mazzaferro, G. Coen, S. Bandini, P.P. Borgatti, M. Ciaccheri, D. Diacinti, E. Ferranti, T. Lusenti, G. Mancini and I. Monducci: “Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus”, Nephrol. Dial. Transpl., Vol. 8(4), (1993), pp. 335–340.Google Scholar
  10. [10]
    E. Straumann, B. Meyer, M. Mitseli, A. Blumberg and H.R. Jenzer: “Aortic and mitral valve disease in patients with end stage renal failure on long term hemodialysis”, Brit. Heart J., Vol. 67(3), (1992), pp. 236–239.PubMedGoogle Scholar
  11. [11]
    E.R. Maher, G. Young, B. Smyth-Walsh, S. Pugh and J.R. Curtis: “Aortic and mitral valve calcification in patients with end stage-stage renal disease”, Lancet, Vol. 330, (1987), pp. 875–877.CrossRefGoogle Scholar
  12. [12]
    E.R. Maher, M. Pazianas and J.R. Curtis: “Calcific aortic stenosis: a complication of chronic uremia”, Nephron, Vol. 42(2), (1987), pp. 119–122.CrossRefGoogle Scholar
  13. [13]
    A.Y. Wang, J. Woo, M. Wang, M.M. Sea, R. Ip, P.K. Li and J.E. Sanderson: “Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients”, J. Am. Soc. Nephrol., Vol. 12(9), (2001), pp. 1927–1936.PubMedGoogle Scholar
  14. [14]
    P. Strozecki, G. Odrowaz-Sypniewska and J. Manitius: “Cardiac valve calcifications and left ventricular hypertrophy in hemodialysis patients”, Renal Failure, Vol. 27, (2005), pp. 733–738.PubMedCrossRefGoogle Scholar
  15. [15]
    P. Raggi, A. Boulay, S. Chasan-Taber, N. Amin, M. Dillon, S.K. Burke and G.M. Chertow: “Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?”, J. Am. Coll. Cardiol., Vol. 39(4), (2002), pp. 695–701.PubMedCrossRefGoogle Scholar
  16. [16]
    S. Ribeiro, A. Ramos, A. Brandao, J.R. Rebelo, A. Guerra, C. Resina, A. Vila-Lobos, F. Carvalho, F. Remedio and F. Ribeiro: “Cardiac valve calcification in hemodialysis patients: role of calcium-phosphate metabolism”, Nephrol. Dial. Transpl., Vol. 13, (1998), pp. 2037–2040.CrossRefGoogle Scholar
  17. [17]
    C.S. Fox, M.G. Larson, R.S. Vasan, C.Y. Guo, H. Parise, D. Levy, E.P. Leip, C.J. O’donnell, R.B. D’Agostino and E.J. Benjamin: “Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study”, J. Am. Soc. Nephrol., Vol. 17(2), (2006) pp. 521–527.PubMedCrossRefGoogle Scholar
  18. [18]
    M. Salgueira, C. Javara, R.M. Alba, J.R. Armas, N. Areste, A. Palma and J.A. Milan: “Valvular heart calcifications in hemodialysis patients: an analysis of predisposed factors”, Nefrologia, Vol. 18, (1998), pp. 221–226.Google Scholar
  19. [19]
    D. Torun, S. Sezer, M. Baltali, F.U. Adam, A. Erdem, F.N. Ozdemir and M. Haberal: “Association of cardiac valve calcification and inflammation in patients on hemodialysis”, Renal Failure, Vol. 27, (2005), pp. 221–226.PubMedGoogle Scholar
  20. [20]
    R.N. Foley, P.S. Parfrey, J.D. Harnett, G.M. Kent, D.C. Murray and P.E. Barre: “Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease”, Kidney Int., Vol. 49(5), (1996), pp. 1379–1385.PubMedCrossRefGoogle Scholar
  21. [21]
    S.G. Rostand and T.B. Drueke: “Parathroid hormone, vitamin D and cardiovascular disease in chronic renal failure”, Kidney Int., Vol. 56(2), (1999), pp. 383–392.PubMedCrossRefGoogle Scholar
  22. [22]
    N.W. Levin and N.A. Hoenich: “Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients”, Curr. Opin. Nephrol. Hy., Vol. 10(5), (2001), pp. 563–568.CrossRefGoogle Scholar
  23. [23]
    T.D. Drüeke: “A clinical approach to the uremic patient with extraskeletal calcifications”, Nephrol. Dial. Transpl., Vol. 11, (1996), pp. 37–42.Google Scholar
  24. [24]
    A. Tenenbaum, J. Shemesh, E.Z. Fisman and M. Motro: “Advanced mitral annular calcification is associated with severe coronary calcification on fast dual spiral computed tomography”, Invest. Radiol., Vol. 35(3), (2000), pp. 193–198.PubMedCrossRefGoogle Scholar
  25. [25]
    J. Zimmermann, S. Herrlinger, A. Pruy, T. Metzger and C. Wanner: “Inflammation enhaces cardiovascular risk and mortality in hemodialysis patients”, Kidney Int., Vol. 55, (1999), pp. 648–658.PubMedCrossRefGoogle Scholar

Copyright information

© Versita Warsaw and Springer-Verlag Berlin Heidelberg 2007

Authors and Affiliations

  • Yusuf Selcoki
    • 1
  • Faruk Turgut
    • 2
  • Mehmet Kanbay
    • 2
  • Adem Ozkara
    • 3
  • Oguz Tekin
    • 3
  • Burak Uz
    • 2
  • Ali Akcay
    • 2
  1. 1.Department of Cardiology, School of MedicineFatih UniversityAnkaraTurkey
  2. 2.Department of Internal Medicine, Division of Nephrology, School of MedicineFatih UniversityAnkaraTurkey
  3. 3.Department of Family Medicine, School of MedicineFatih UniversityAnkaraTurkey

Personalised recommendations